Minerva Neurosciences to Present at JMP Securities CNS Forum
August 13, 2020 08:00 ET
|
Minerva Neurosciences, Inc
WALTHAM, Mass., Aug. 13, 2020 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat...